The estimated Net Worth of Nicholas J Iii Simon is at least $65 Million dollars as of 31 August 2004. Nicholas Simon owns over 85,027 units of Rigel Pharmaceuticals stock worth over $21,881,324 and over the last 21 years Nicholas sold RIGL stock worth over $43,070,700.
Nicholas has made over 18 trades of the Rigel Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Nicholas sold 868,055 units of RIGL stock worth $20,390,612 on 23 November 2004.
The largest trade Nicholas's ever made was selling 868,055 units of Rigel Pharmaceuticals stock on 23 November 2004 worth over $20,390,612. On average, Nicholas trades about 92,598 units every 13 days since 2004. As of 31 August 2004 Nicholas still owns at least 1,687,072 units of Rigel Pharmaceuticals stock.
You can see the complete history of Nicholas Simon stock trades at the bottom of the page.
Nicholas's mailing address filed with the SEC is 6300 Dumbarton Cir, Fremont, CA 94555, USA.
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke, and Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: